First-in-human phase I study of ALT-P7, a HER2-targeting antibody-drug conjugate in patients with HER2-positive advanced breast cancer.

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 38, Issue 15_suppl, Pages 3551-3551

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2020-05-25

DOI

10.1200/jco.2020.38.15_suppl.3551

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.